Autoimmune, oncology, diabetes and obesity rule drug spending

Chronic conditions drive key drug spend classes

Large populations combined with costly medications equates to big spending. With new drugs seeming to arrive daily and typically costing more than old drugs, overall spending continues to rise. And while the top drugs may change, the top categories in drug spend stay the same.

With many patients and expensive treatments, immunology, oncology, and diabetes are the top drivers of overall drug spending. Not just today, but for years to come.

In this report, get the breakdown of the top spending categories — including drug costs and competition — along with strategies to combat them.